Citations (61)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Areana Diogo Nascimento, Lucia Alves Silva Lara, Ana Carolina Japur de Sá Rosa-e-Silva, Rui Alberto Ferriani & Rosana Maria Reis. (2013) Effects of metformin on serum insulin and anti-mullerian hormone levels and on hyperandrogenism in patients with polycystic ovary syndrome. Gynecological Endocrinology 29:3, pages 246-249.
Read now
Read now
L. Mohiyiddeen, A. J. Watson, N. V. Apostolopoulos, R. Berry, K. I. Alexandraki & E. B. Jude. (2013) Effects of low-dose metformin and rosiglitazone on biochemical, clinical, metabolic and biophysical outcomes in polycystic ovary syndrome. Journal of Obstetrics and Gynaecology 33:2, pages 165-170.
Read now
Read now
Ahmed Badawy & Abubaker Elnashar. (2011) Treatment options for polycystic ovary syndrome. International Journal of Women's Health 3, pages 25-35.
Read now
Read now
Dorte Glintborg & Marianne Andersen. (2010) Thiazolinedione treatment in PCOS – an update. Gynecological Endocrinology 26:11, pages 791-803.
Read now
Read now
Camil Castelo-Branco & María Jesús Cancelo. (2010) Comprehensive clinical management of hirsutism. Gynecological Endocrinology 26:7, pages 484-493.
Read now
Read now
Marie-Hélène Massicotte, Fabienne Langlois & Jean-Patrice Baillargeon. (2010) Current procedures for managing polycystic ovary syndrome. Expert Review of Obstetrics & Gynecology 5:1, pages 77-91.
Read now
Read now
Shahla Nader. (2008) Treatment for polycystic ovary syndrome: a critical appraisal of treatment options. Expert Review of Endocrinology & Metabolism 3:3, pages 349-359.
Read now
Read now
Marie-Hélène Pesant & Jean-Patrice Baillargeon. (2006) Comparing rosiglitazone with ethinylestradiol/cyproterone acetate in the treatment of polycystic ovary syndrome. Expert Review of Obstetrics & Gynecology 1:1, pages 81-92.
Read now
Read now
Articles from other publishers (53)
Johanna M. Melin, Maria Forslund, Simon J. Alesi, Terhi Piltonen, Daniela Romualdi, Poli M. Spritzer, Chau Thien Tay, Alexia S. Pena, Selma F. Witchel, Aya Mousa & Helena J. Teede. (2023) Effects of different insulin sensitisers in the management of polycystic ovary syndrome: A systematic review and meta‐analysis. Clinical Endocrinology.
Crossref
Crossref
Wisam Akram, Wassan Nori & Muna Abdul Ghani Zghair. (2023) Metformin effect on internal carotid artery blood flow assessed by area under the curve of carotid artery Doppler in women with polycystic ovarian syndrome. World Journal of Clinical Cases 11:6, pages 1318-1329.
Crossref
Crossref
Mohammed A. Abdalla, Najeeb Shah, Harshal Deshmukh, Amirhossein Sahebkar, Linda Östlundh, Rami H. Al‐Rifai, Stephen L. Atkin & Thozhukat Sathyapalan. (2022) Impact of pharmacological interventions on anthropometric indices in women with polycystic ovary syndrome: A systematic review and meta‐analysis of randomized controlled trials. Clinical Endocrinology 96:6, pages 758-780.
Crossref
Crossref
Mohammed Altigani Abdalla, Najeeb Shah, Harshal Deshmukh, Amirhossein Sahebkar, Linda Östlundh, Rami H. Al-Rifai, Stephen L. Atkin & Thozhukat Sathyapalan. (2022) Impact of pharmacological interventions on biochemical hyperandrogenemia in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomised controlled trials. Archives of Gynecology and Obstetrics 307:5, pages 1347-1376.
Crossref
Crossref
Mohammed A. Abdalla, Najeeb Shah, Harshal Deshmukh, Amirhossein Sahebkar, Linda Östlundh, Rami H. Al‐Rifai, Stephen L. Atkin & Thozhukat Sathyapalan. (2021) Impact of pharmacological interventions on insulin resistance in women with polycystic ovary syndrome: A systematic review and meta‐analysis of randomized controlled trials. Clinical Endocrinology 96:3, pages 371-394.
Crossref
Crossref
Dalal Kojok, Ghina Ghazeeri & Johnny T. Awwad. 2022. Polycystic Ovary Syndrome. Polycystic Ovary Syndrome
233
253
.
Monika Joshi, Ravi Shankar, Kamla Pathak & Ramakant Yadav. (2021) Polycystic ovarian syndrome: A review covering phytoconstituents for its outstrip management. Pharmacological Research - Modern Chinese Medicine 1, pages 100011.
Crossref
Crossref
Mohamed Abdel-Maboud, Amr Menshawy, Elfatih A. Hasabo, Mohamed Ibrahim Abdelraoof, Mohamed Alshandidy, Muhammad Eid, Esraa Menshawy, Oumaima Outani & Ahmed Menshawy. (2021) The comparative effectiveness of 55 interventions in obese patients with polycystic ovary syndrome: A network meta-analysis of 101 randomized trials. PLOS ONE 16:7, pages e0254412.
Crossref
Crossref
Jeshica Bulsara, Priyanshi Patel, Arun Soni & Sanjeev Acharya. (2021) A review: Brief insight into Polycystic Ovarian syndrome. Endocrine and Metabolic Science 3, pages 100085.
Crossref
Crossref
Ziba MajidiShaghayegh HosseinkhaniNasrin Amiri-DashatanSolaleh EmamgholipourSara TutunchiJavad HashemiFatemeh GhorbaniMehdi Koushki. (2023) Effect of Rosiglitazone on Circulating Malondialdehyde (Mda) Level in Diabetes Based on a Systematic Review and Meta-Analysis of Eight Clinical Trials. Journal of Investigative Medicine 69:3, pages 697-703.
Crossref
Crossref
Yuval Ramot, Marta Bertolini, Maria Boboljova, Yoshikazu Uchida & Ralf Paus. (2019) PPAR‐γ signalling as a key mediator of human hair follicle physiology and pathology. Experimental Dermatology 29:3, pages 312-321.
Crossref
Crossref
Yujing Li, Jing Tan, Qiuyi Wang, Changling Duan, Yuanyuan Hu & Wei Huang. (2020) Comparing the individual effects of metformin and rosiglitazone and their combination in obese women with polycystic ovary syndrome: a randomized controlled trial. Fertility and Sterility 113:1, pages 197-204.
Crossref
Crossref
Rong Huang, Peng‐Fei Zhao, Jian‐Hua Xu, Dong‐Dong Liu, Fu‐Dong Luo & Yong‐Hui Dai. (2017) Effects of placebo‐controlled insulin‐sensitizing drugs on hormonal parameters in polycystic ovary syndrome patients: A network meta‐analysis. Journal of Cellular Biochemistry 119:3, pages 2501-2511.
Crossref
Crossref
I. Haj-Husein, S. Tukan & F. Alkazaleh. (2016)
The effect of marjoram (
Origanum majorana
) tea on the hormonal profile of women with polycystic ovary syndrome: a randomised controlled pilot study
. Journal of Human Nutrition and Dietetics 29:1, pages 105-111.
Crossref
Crossref
. 2016. Meyler's Side Effects of Drugs. Meyler's Side Effects of Drugs
851
873
.
Mrinal Gupta, Vikram K. Mahajan, Karaninder S. Mehta, Pushpinder S. Chauhan & Ritu Rawat. (2015) Peroxisome proliferator-activated receptors (PPARs) and PPAR agonists: the ‘future’ in dermatology therapeutics?. Archives of Dermatological Research 307:9, pages 767-780.
Crossref
Crossref
Esther J van Zuuren, Zbys Fedorowicz, Ben Carter & Nikolaos Pandis. (2015) Interventions for hirsutism (excluding laser and photoepilation therapy alone). Cochrane Database of Systematic Reviews 2017:5.
Crossref
Crossref
Elizabeth Buzney, Johanna Sheu, Catherine Buzney & Rachel V. Reynolds. (2014) Polycystic ovary syndrome: A review for dermatologists. Journal of the American Academy of Dermatology 71:5, pages 859.e1-859.e15.
Crossref
Crossref
Najwa Somani & Diane Turvy. (2014) Hirsutism: An Evidence-Based Treatment Update. American Journal of Clinical Dermatology 15:3, pages 247-266.
Crossref
Crossref
Ghada Abdel Fattah, Maged Al Mohammady & Dalia Ahmed Hamed. (2014) Combined pioglitazone–metformin and clomiphene citrate versus metformin and clomiphene citrate in induction of ovulation in women with clomiphene citrate-resistant polycystic ovary syndrome. Middle East Fertility Society Journal 19:1, pages 27-33.
Crossref
Crossref
Johnny T. Awwad & Ghina Ghazeeri. 2014. Polycystic Ovary Syndrome. Polycystic Ovary Syndrome
165
180
.
Ladan Kashani, Targol Omidvar, Behnoud Farazmand, Amirhossein Modabbernia, Fatemeh Ramzanzadeh, Ensiyeh Shahrokh Tehraninejad, Mandana Ashrafi, Mina Tabrizi & Shahin Akhondzadeh. (2013) Does pioglitazone improve depression through insulin-sensitization? Results of a randomized double-blind metformin-controlled trial in patients with polycystic ovarian syndrome and comorbid depression. Psychoneuroendocrinology 38:6, pages 767-776.
Crossref
Crossref
Ulrike Blume-Peytavi. (2013) How to Diagnose and Treat Medically Women with Excessive Hair. Dermatologic Clinics 31:1, pages 57-65.
Crossref
Crossref
H.F. Escobar-Morreale, E. Carmina, D. Dewailly, A. Gambineri, F. Kelestimur, P. Moghetti, M. Pugeat, J. Qiao, C.N. Wijeyaratne, S.F. Witchel & R.J. Norman. (2012) Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society. Human Reproduction Update 18:2, pages 146-170.
Crossref
Crossref
X-J. Li, Y-X. Yu, C-Q. Liu, W. Zhang, H-J. Zhang, B. Yan, L-Y. Wang, S-Y. Yang & S-H. Zhang. (2011) Metformin vs thiazolidinediones for treatment of clinical, hormonal and metabolic characteristics of polycystic ovary syndrome: a meta-analysis. Clinical Endocrinology 74:3, pages 332-339.
Crossref
Crossref
Maria Orbetzova, Blagovest Pehlivanov, Mitko Mitkov, Iliana Atanassova, Zdravko Kamenov, Georgi Kolarov & Gencho Genchev. (2011) Effect of Short-Term Standard Therapeutic Regimens on Neuropeptide Y and Adipose Tissue Hormones in Overweight Insulinresistant Women with Polycystic Ovary Syndrome. Folia Medica 53:3.
Crossref
Crossref
Almudena Veiga-Lopez, James S. Lee & Vasantha Padmanabhan. (2010) Developmental Programming: Insulin Sensitizer Treatment Improves Reproductive Function in Prenatal Testosterone-Treated Female Sheep. Endocrinology 151:8, pages 4007-4017.
Crossref
Crossref
Daimarys Quintero-Castillo, Hedy Luz-Araujo, Mery Guerra-Velázquez, Eduardo Reyna-Villasmil, Joel Santos Bolívar, Duly Torres-Cepeda, Jorly Mejia-Montilla & Nadia Reyna-Villasmil. (2010) Perfil lipídico en mujeres obesas y no obesas con síndrome de ovarios poliquísticos tratadas con metformina. Endocrinología y Nutrición 57:6, pages 262-267.
Crossref
Crossref
Ting-ting HAN, Jun ZHENG & Yao-min HU. (2010) Thiazolidinediones combined with metformin in treatment of polycystic ovary syndrome: a systematic review. Academic Journal of Second Military Medical University 30:4, pages 412-416.
Crossref
Crossref
Katie Colwell, Marla E. Lujan, Karen L. Lawson, Roger A. Pierson & Donna R. Chizen. (2010) Women's Perceptions of Polycystic Ovary Syndrome Following Participation in a Clinical Research Study: Implications for Knowledge, Feelings, and Daily Health Practices. Journal of Obstetrics and Gynaecology Canada 32:5, pages 453-459.
Crossref
Crossref
Niki Katsiki, Eleni Georgiadou & Apostolos I. Hatzitolios. (2009) The Role of Insulin-Sensitizing Agents in the Treatment of Polycystic Ovary Syndrome. Drugs 69:11, pages 1417-1431.
Crossref
Crossref
. 2009. Meyler's Side Effects of Endocrine and Metabolic Drugs. Meyler's Side Effects of Endocrine and Metabolic Drugs
357
473
.
Jean-Patrice Baillargeon & Nadir R. Farid. 2009. Diagnosis and Management of Polycystic Ovary Syndrome. Diagnosis and Management of Polycystic Ovary Syndrome
209
232
.
Laura A. Ruby. (2008) Polycystic Ovarian Syndrome. The Journal for Nurse Practitioners 4:9, pages 697-704.
Crossref
Crossref
Kabli Nadia & Tulandi Togas. 2010. Infertility and Assisted Reproduction. Infertility and Assisted Reproduction
286
293
.
Ulrike Blume-Peytavi & Susanne Hahn. (2008) Medical treatment of hirsutism. Dermatologic Therapy 21:5, pages 329-339.
Crossref
Crossref
Aldo Galluzzo, Marco Calogero Amato & Carla Giordano. (2008) Insulin resistance and polycystic ovary syndrome. Nutrition, Metabolism and Cardiovascular Diseases 18:7, pages 511-518.
Crossref
Crossref
Jamal Ahmad, Nidhi Shukla, Abdur Rahman Khan, Faiz Ahmed & M. Asim Siddiqui. (2008) Comparison of metabolic effects of metformin and rosiglitazone in the management of polycystic ovary syndrome (PCOS): A prospective, parallel, randomized, open-label study. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2:1, pages 37-46.
Crossref
Crossref
Cadence E. Minge, Rebecca L. Robker & Robert J. Norman. (2008) PPAR Gamma: Coordinating Metabolic and Immune Contributions to Female Fertility. PPAR Research 2008, pages 1-19.
Crossref
Crossref
R.C.L. Page. 2008. A worldwide yearly survey of new data and trends in adverse drug reactions and interactions. A worldwide yearly survey of new data and trends in adverse drug reactions and interactions
494
506
.
Robert J. Norman, Anneloes E. Ruifrok, Lisa J. Moran & Rebecca L. Robker. 2008. Polycystic Ovary Syndrome. Polycystic Ovary Syndrome
259
279
.
Evanthia Diamanti-Kandarakis. 2008. Polycystic Ovary Syndrome. Polycystic Ovary Syndrome
197
215
.
A. Torre & H. Fernandez. (2007) Le syndrome des ovaires polykystiques (SOPK). Journal de Gynécologie Obstétrique et Biologie de la Reproduction 36:5, pages 423-446.
Crossref
Crossref
Tessa G Lebinger. (2007) Metformin and polycystic ovary syndrome. Current Opinion in Endocrinology, Diabetes & Obesity 14:2, pages 132-140.
Crossref
Crossref
Richard S. Legro, Richard J. Zaino, Laurence M. Demers, Allen R. Kunselman, Carol L. Gnatuk, Nancy I. Williams & William C. Dodson. (2007) The effects of metformin and rosiglitazone, alone and in combination, on the ovary and endometrium in polycystic ovary syndrome. American Journal of Obstetrics and Gynecology 196:4, pages 402.e1-402.e11.
Crossref
Crossref
SUMA DRONAVALLI & DAVID A. EHRMANN. (2007) Pharmacologic Therapy of Polycystic Ovary Syndrome. Clinical Obstetrics and Gynecology 50:1, pages 244-254.
Crossref
Crossref
Amy T Lee & Lee T Zane. (2007) Dermatologic Manifestations of Polycystic Ovary Syndrome. American Journal of Clinical Dermatology 8:4, pages 201-219.
Crossref
Crossref
E A Pigarova & L K Dzeranova. (2006) Novye gorizonty primeneniya tiazolidindionov. Obesity and metabolism 3:4, pages 12-20.
Crossref
Crossref
Tarik A. ElhaddTarek FiadLorna Meer. (2006) Ovarian Stockpiling in Polycystic Ovary Syndrome, Infertility, and the Combined Use of Rosiglitazone and Metformin. Diabetes Care 29:10, pages 2330-2331.
Crossref
Crossref
Nadia F. Soliman & Peter G. Wardle. (2006) The investigation and management of the hirsute woman. Reviews in Gynaecological and Perinatal Practice 6:3-4, pages 145-152.
Crossref
Crossref
Yared N Demissie, Tarek M Fiad, Katja Klemm, Afaf Twfeeg, Abdullah Al-Amoudi, Lorna Meer & Tarik A Elhadd. (2006) Spontaneous singleton and twin pregnancy in two patients with polycystic ovary syndrome and type 2 diabetes following treatment with metformin combined with rosiglitazone. Annals of Saudi Medicine 26:4, pages 296-299.
Crossref
Crossref
Maggi Banning. (2006) Symptoms and treatments of polycystic ovary syndrome. British Journal of Nursing 15:12, pages 635-639.
Crossref
Crossref
Pascal Froment & Philippe Touraine. (2006) Thiazolidinediones and Fertility in Polycystic Ovary Syndrome (PCOS). PPAR Research 2006, pages 1-8.
Crossref
Crossref